Clin Mol Hepatol.
2023 Jan;29(1):105-109. 10.3350/cmh.2022.0361.
Non-invasive tests-based risk stratification: Baveno VII and beyond
- Semmler G
1,2 - Jachs M1,2
- Mandorfer M1,2
- Affiliations
-
- 1Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
- 2Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
- KMID: 2538205
- DOI: http://doi.org/10.3350/cmh.2022.0361
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus
- Application of Baveno Criteria and Modified Baveno Criteria with Shear-wave Elastography in Compensated Advanced Chronic Liver Disease
- Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
- Risk Stratification of Acute Coronary Syndrome
- Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
